Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

NCT05371093 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Follicular Lymphoma

Interventions

BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Bendamustine

Sponsor

Kite, A Gilead Company